{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T05:50:05Z","timestamp":1669441805868},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Schleswig-Holstein - Campus Kiel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00066-022-02016-y","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T15:10:14Z","timestamp":1666278614000},"page":"1122-1124","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Boost und Hypofraktionierung beim DCIS"],"prefix":"10.1007","volume":"198","author":[{"given":"J\u00fcrgen","family":"Dunst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Krug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"2016_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","volume":"16","author":"H Bartelink","year":"2015","unstructured":"Bartelink\u00a0H, Maingon\u00a0P, Poortmans\u00a0P et al (2015) Whole-breast irradiation with or without a\u00a0boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a\u00a0randomised phase 3 trial. Lancet Oncol 16:47\u201356","journal-title":"Lancet Oncol"},{"key":"2016_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0140-6736(22)01246-6","volume":"400","author":"BH Chua","year":"2022","unstructured":"Chua\u00a0BH, Link\u00a0EK, Kunkler\u00a0IH et al (2022) Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3\u201307\/TROG 07.01): a\u00a0randomised, factorial, multicentre, open-label, phase 3\u00a0study. Lancet 400:431\u2013440","journal-title":"Lancet"},{"key":"2016_CR3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0140-6736(22)01381-2","volume":"400","author":"CE Coles","year":"2022","unstructured":"Coles\u00a0CE, Chatterjee\u00a0S, Jagsi\u00a0R, Kirby\u00a0AM (2022) Breast radiotherapy for ductal carcinoma in situ: could less be more? Lancet 400:408\u2013411","journal-title":"Lancet"},{"key":"2016_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","volume":"41","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2010","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (2010) Overview of the randomised trials of radiotherapy in ductal carcinoma in situ of the breast. J\u00a0Natl Cancer Inst Monogr 41:162\u2013177","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2016_CR5","unstructured":"Interdisziplin\u00e4re S3-Leitlinie f\u00fcr die Fr\u00fcherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms, Version 4.4. von Juni 2021. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/032-045OLl_S3_Mammakarzinom_2021-07.pdf. Zugriff 9. Sept. 2022"},{"key":"2016_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.breast.2022.01.018","volume":"62","author":"GN Marta","year":"2022","unstructured":"Marta\u00a0GN, Riera\u00a0R, Pacheco\u00a0RL et al (2022) Moderately hypofractionated post-operative radiation therapy for breast cancer: systematic review and meta-analysis of randomized clinical trials. Breast 62:84\u201389","journal-title":"Breast"},{"key":"2016_CR7","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1200\/JCO.21.01083","volume":"39","author":"B McCormick","year":"2021","unstructured":"McCormick\u00a0B, Winter\u00a0KA, Woodward\u00a0W et al (2021) Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG oncology\/RTOG 9804. J\u00a0Clin Oncol 39:3574\u20133582","journal-title":"J Clin Oncol"},{"key":"2016_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","volume":"33","author":"B McCormick","year":"2015","unstructured":"McCormick\u00a0B, Winter\u00a0K, Hudis\u00a0C et al (2015) RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J\u00a0Clin Oncol 33:709\u2013715","journal-title":"J Clin Oncol"},{"key":"2016_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamaoncol.2016.6948","volume":"3","author":"MS Moran","year":"2017","unstructured":"Moran\u00a0MS, Zhao\u00a0Y, Ma\u00a0S et al (2017) Association of radiotherapy boost for ductal carcinoma in situ with local control after whole-breast radiotherapy. JAMA Oncol 3:1060\u20131068","journal-title":"JAMA Oncol"},{"key":"2016_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.radonc.2015.01.001","volume":"114","author":"C Nilsson","year":"2015","unstructured":"Nilsson\u00a0C, Valachis\u00a0A (2015) The role of boost and hypofractionation as adjuvant radiotherapy in patients with DCIS: a\u00a0meta-analysis of observational studies. Radiother Oncol 114:50\u201355","journal-title":"Radiother Oncol"},{"key":"2016_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1200\/JCO.1997.15.3.963","volume":"15","author":"P Romestaing","year":"1997","unstructured":"Romestaing\u00a0P, Lehingue\u00a0Y, Carrie\u00a0C et al (1997) Role of a\u00a010-Gy boost in the conservative treatment of early breast cancer: results of a\u00a0randomized clinical trial in Lyon, France. J\u00a0Clin Oncol 15:963\u2013968","journal-title":"J Clin Oncol"},{"key":"2016_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0360-3016(99)00211-4","volume":"45","author":"C Vrieling","year":"1999","unstructured":"Vrieling\u00a0C, Collette\u00a0L, Fourquet\u00a0A et al (1999) The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC \u201cboost versus no boost\u201d trial. Int J Radiat Oncol Biol Phys 45:677\u2013685","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-02016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-022-02016-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-02016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T09:13:08Z","timestamp":1669367588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-022-02016-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2016"],"URL":"https:\/\/doi.org\/10.1007\/s00066-022-02016-y","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"26 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0Dunst und D.\u00a0Krug geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}